Xiphodynia as an Unusual Cause of Chest Pain: A Case Series.

IF 0.8 Q4 SURGERY
Anniek van Boekel, Guido Stollenwerck, Ewan D Ritchie, Sanne Vogels
{"title":"Xiphodynia as an Unusual Cause of Chest Pain: A Case Series.","authors":"Anniek van Boekel,&nbsp;Guido Stollenwerck,&nbsp;Ewan D Ritchie,&nbsp;Sanne Vogels","doi":"10.1055/s-0043-1761270","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction</b>  Treatment options for xiphodynia are injections with local corticosteroid injections or surgical resection of the xiphoid process. Currently, there is no consensus as to which treatment is the most optimal. <b>Objectives</b>  The aim of this case series was to compare the safety and efficacy of conservative and surgical treatment for patients with xiphodynia. <b>Patients and Methods</b>  A retrospective case series was performed. All patients presenting with xiphodynia between 2016 and 2021 were eligible. Demographic data and treatment regimes, including preoperative work-up and surgical technique, were extracted from the electronic patient files. In addition, all patients received a follow-up phone call with a questionnaire. Patient satisfaction was measured using the Numeric Rating Scale. <b>Results</b>  A total of five patients, suffering from xiphodynia for up to 10 years, completed the follow-up questionnaire (median patient age, 57 years; range 51-68 years). Three of these patients initially received conservative treatment with local injections with corticosteroids for at least 6 months. One patient was satisfied with the results and did not opt for surgical treatment. Eventually, four patients were treated surgically by removing the xiphoid process. No postoperative complications were recorded and 100% of the patients who underwent a xiphoidectomy were free of symptoms and satisfied with the results. <b>Conclusion</b>  Symptoms related to xiphodynia can be relieved using conservative or surgical treatment, where the latter seems to be a safe and effective solution.</p>","PeriodicalId":44614,"journal":{"name":"Surgery Journal","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904973/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0043-1761270","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction  Treatment options for xiphodynia are injections with local corticosteroid injections or surgical resection of the xiphoid process. Currently, there is no consensus as to which treatment is the most optimal. Objectives  The aim of this case series was to compare the safety and efficacy of conservative and surgical treatment for patients with xiphodynia. Patients and Methods  A retrospective case series was performed. All patients presenting with xiphodynia between 2016 and 2021 were eligible. Demographic data and treatment regimes, including preoperative work-up and surgical technique, were extracted from the electronic patient files. In addition, all patients received a follow-up phone call with a questionnaire. Patient satisfaction was measured using the Numeric Rating Scale. Results  A total of five patients, suffering from xiphodynia for up to 10 years, completed the follow-up questionnaire (median patient age, 57 years; range 51-68 years). Three of these patients initially received conservative treatment with local injections with corticosteroids for at least 6 months. One patient was satisfied with the results and did not opt for surgical treatment. Eventually, four patients were treated surgically by removing the xiphoid process. No postoperative complications were recorded and 100% of the patients who underwent a xiphoidectomy were free of symptoms and satisfied with the results. Conclusion  Symptoms related to xiphodynia can be relieved using conservative or surgical treatment, where the latter seems to be a safe and effective solution.

Abstract Image

剑痛是胸痛的一个不寻常的原因:一个病例系列。
剑突痛的治疗选择是局部注射皮质类固醇或手术切除剑突。目前,对于哪种治疗方法是最佳的,还没有达成共识。目的:本病例系列的目的是比较保守治疗和手术治疗对剑痛患者的安全性和有效性。患者和方法回顾性分析了一系列病例。2016年至2021年期间出现剑痛的所有患者均符合条件。从电子患者档案中提取人口统计数据和治疗方案,包括术前检查和手术技术。此外,所有患者都接受了随访电话调查问卷。采用数字评定量表测量患者满意度。结果5例剑痛患者完成了随访问卷(患者年龄中位数为57岁;范围51-68年)。其中3例患者最初接受保守治疗,局部注射皮质类固醇至少6个月。1例患者对结果满意,不选择手术治疗。最终,四名患者通过手术切除了剑突。无术后并发症记录,100%接受剑突切除术的患者无症状,效果满意。结论保守治疗或手术治疗均可缓解剑痛症状,其中手术治疗安全有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Surgery Journal
Surgery Journal SURGERY-
自引率
0.00%
发文量
64
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信